Cell Pouch Technology Delivers Functional Cures for Chronic Diseases with Cynthia Pussinen Sernova TRANSCRIPT
Download PDFApr 2, 2024
Cynthia Pussinen, CEO of Sernova, describes their innovative cell therapy platform, the Cell Pouch System, which can deliver functional cures for chronic diseases using therapeutic cells, tissues, proteins, and other molecules. This implantable device is made of mesh that allows for vascularization, forming...
Apr 2, 2024
Cynthia Pussinen, CEO of Sernova, describes their innovative cell therapy platform, the Cell Pouch System, which can deliver functional cures for chronic diseases using therapeutic cells, tissues, proteins, and other molecules. This implantable device is made of mesh that allows for vascularization, forming...
Innovative Platform for Treating Periodontal Disease Regenerating Bone in Humans and Animals with Stella Vnook and Bill Breitenbach Oral Bio Life TRANSCRIPT
Download PDFMar 18, 2024
Stella Vnook, the Founder and President, and Bill Breitenbach, CEO of Oral Bio Life, talk about the prevalence and causes of periodontal disease and the limitations of current treatments. The Oral Bio Life PiezoGEL technology has shown effective removal of plaque and treatment of bacteria on teeth and regenerating bone...
Mar 18, 2024
Stella Vnook, the Founder and President, and Bill Breitenbach, CEO of Oral Bio Life, talk about the prevalence and causes of periodontal disease and the limitations of current treatments. The Oral Bio Life PiezoGEL technology has shown effective removal of plaque and treatment of bacteria on teeth and regenerating bone...
Role of Laparoscopic Surgery and GLP-1 Agonists in Weight Loss and Weight Management with Paul Hickey ReShape Lifesciences TRANSCRIPT
Download PDFMar 6, 2024
Paul Hickey, President and CEO of ReShape Lifesciences, discusses the company's role in the weight loss industry. The ReShape Lap-Band® and the new ReShape Lap-Band® 2.0 FLEX are tested surgical options for weight loss and weight management and are now being joined in the market by GLP-1 agonists such as Wegovy and...